Furiex Pharmaceuticals, Inc. 4
4 · Furiex Pharmaceuticals, Inc. · Filed Jun 21, 2010
Insider Transaction Report
Form 4
COVINGTON PAUL S
Senior VP-Clinical Operations
Transactions
- Award
Stock Options (to buy)
2010-06-17+75,691→ 75,691 totalExercise: $9.11Exp: 2020-06-17→ Common Stock (75,691 underlying)
Holdings
- 73
Common Stock
Footnotes (2)
- [F1]Represents shares acquired in a pro rata distribution by PPDI.
- [F2]The options were awarded on 06/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided that the Optionee's employment continues.